Extension of Time to File SOU

ASSEMBLYBIO

Assembly Biosciences, Inc.

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88377629
LAW OFFICE ASSIGNED LAW OFFICE 127
MARK SECTION
MARK ASSEMBLYBIO (see, http://uspto.report/TM/88377629/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ASSEMBLYBIO
OWNER SECTION (current)
NAME Assembly Biosciences, Inc.
STREET 11711 North Meridian Street, Suite 310
CITY Carmel
STATE Indiana
ZIP/POSTAL CODE 46032
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME Assembly Biosciences, Inc.
STREET 11711 North Meridian Street, Suite 310
CITY Carmel
STATE Indiana
ZIP/POSTAL CODE 46032
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Jessica L. Rothstein
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE TMadmin@goodwinlaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) jrothstein@goodwinlaw.com; SAlliRampersad@goodwinlaw.com
CORRESPONDENCE INFORMATION (proposed)
NAME Jessica L. Rothstein
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE TMadmin@goodwinlaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) jrothstein@goodwinlaw.com; SAlliRampersad@goodwinlaw.com
DOCKET/REFERENCE NUMBER ASP-612
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Biopharmaceutical products, namely, pharmaceutical preparations for treating infectious diseases, gastrointestinal dysbiosis, auto-immune disorders, non-alcoholic steatohepatitis (NASH), immuno-oncology, metabolic disease, autism and oncologic conditions; Drug delivery systems in the form of capsules, tablets, softgels, powders, films and liquids that facilitate delivery of a wide range of pharmaceuticals; Drug delivery systems consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 042
CURRENT IDENTIFICATION Research and development in the bio-science and biotechnology fields; Pharmaceutical, Medical and Scientific research and development services; Pharmaceutical products development; Pharmaceutical drug development services; Clinical research in the field of medicine, therapeutics and pharmaceutical development; Conducting clinical trials for others; Drug discovery services
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 09/24/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 2
SUBTOTAL AMOUNT [EXTENSION FEE] 250
TOTAL AMOUNT 250
SIGNATURE SECTION
SIGNATURE /Elizabeth H. Lacy/
SIGNATORY'S NAME Elizabeth H. Lacy
SIGNATORY'S POSITION General Counsel, Vice President of Legal Operations
DATE SIGNED 03/19/2020
SIGNATORY'S PHONE NUMBER 317.975.2699
FILING INFORMATION
SUBMIT DATE Thu Mar 19 22:00:10 ET 2020
TEAS STAMP USPTO/ESU-XX.XXX.XX.XX-20
200319220010663346-883776
29-7109230d587c8d079c2a68
18d7bd9596d64ec7d3efa6f49
1e24efa51cb775be26f6-CC-0
0090981-20200317194039707
420



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: ASSEMBLYBIO (see, http://uspto.report/TM/88377629/mark.png)
SERIAL NUMBER: 88377629

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Assembly Biosciences, Inc., having an address of
      11711 North Meridian Street, Suite 310
      Carmel, Indiana 46032
      United States
      Email: XXXX
Proposed: Assembly Biosciences, Inc., having an address of BB
      11711 North Meridian Street, Suite 310
      Carmel, Indiana 46032
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 09/24/2019.

For International Class 005:
Current identification: Biopharmaceutical products, namely, pharmaceutical preparations for treating infectious diseases, gastrointestinal dysbiosis, auto-immune disorders, non-alcoholic steatohepatitis (NASH), immuno-oncology, metabolic disease, autism and oncologic conditions; Drug delivery systems in the form of capsules, tablets, softgels, powders, films and liquids that facilitate delivery of a wide range of pharmaceuticals; Drug delivery systems consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 042:
Current identification: Research and development in the bio-science and biotechnology fields; Pharmaceutical, Medical and Scientific research and development services; Pharmaceutical products development; Pharmaceutical drug development services; Clinical research in the field of medicine, therapeutics and pharmaceutical development; Conducting clinical trials for others; Drug discovery services

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      Jessica L. Rothstein
      PRIMARY EMAIL FOR CORRESPONDENCE: TMadmin@goodwinlaw.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jrothstein@goodwinlaw.com; SAlliRampersad@goodwinlaw.com

Correspondence Information (proposed):
      Jessica L. Rothstein
      PRIMARY EMAIL FOR CORRESPONDENCE: TMadmin@goodwinlaw.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jrothstein@goodwinlaw.com; SAlliRampersad@goodwinlaw.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Elizabeth H. Lacy/      Date Signed: 03/19/2020
Signatory's Name: Elizabeth H. Lacy
Signatory's Position: General Counsel, Vice President of Legal Operations
Signatory's Phone: 317.975.2699

RAM Sale Number: 88377629
RAM Accounting Date: 03/19/2020

Serial Number: 88377629
Internet Transmission Date: Thu Mar 19 22:00:10 ET 2020
TEAS Stamp: USPTO/ESU-XX.XXX.XX.XX-20200319220010663
346-88377629-7109230d587c8d079c2a6818d7b
d9596d64ec7d3efa6f491e24efa51cb775be26f6
-CC-00090981-20200317194039707420




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed